2021 was a breakout year for special purpose acquisition corporation mergers in medtech. A look at what these companies are up to now.

Last year medtech jumped head-first into special purpose acquisition corporation mergers. Some of the bigger private companies in the industry went public via the SPAC route.  By far SPACs were one of medtech’s hottest trends.

MD+DI is taking a look at what these companies have accomplished since going public through a SPAC.